WASHINGTON — The U.S. Food and Drug Administration has approved a reformulated version of ranitidine, which was sold widely under the brand name Zantac, allowing the acid-reducing drug to return to ...
A Delaware judge has dismissed a request from GSK Plc (NYSE:GSK) and other pharmaceutical companies to appeal a ruling that allows over 70,000 lawsuits alleging the heartburn drug Zantac causes cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback